Skip to content
OpenCapital
Get started

Exagen Inc. XGN Q4 2025 Annual earnings

Reported March 10, 2026 · Before market open

Revenue$16.6MBeat by $60.7K
EPS-$0.20In line
Revenue estimate$16.6M
EPS estimate-$0.20

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$17.8M
EPS estimate-$0.19

Financials

Q4 2025

Income statement

See full
Revenue$16.6M+21.8%
Gross profit$9.2M+8.6%
Operating income-$5.0M-47.1%
Net income-$4.7M-24.2%
EPS (diluted)-$0.200.0%

Balance sheet

See full
Cash & equivalents$32.4M+45.8%
Total debt$27.7M+18.4%
Total equity$17.4M+82.9%
Total assets$58.0M+29.8%

Cash flow

See full
Operating cash flow-$3.0M—
CapEx$44.0K-69.9%
Free cash flow-$3.1M—

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$137.79M+90.5%
Enterprise value$133.04M+81.2%
P/S2.1×+0.8×

Profitability

See full
Gross margin58.3%-1.2pp
Operating margin-21.1%-2.6pp
Net margin-30%+3.4pp

Returns & leverage

See full
Return on equity-147.8%+201pp
Debt / equity1.6×-0.9×
Current ratio3.5×+0.8×

Segments

By segment

See full
Reportable Segment$16.6M+21.8%

Versus estimates

Revenue

Q1 2026$17.3MBeat by $897.4K
Q4 2025$16.6MBeat by $60.7K
Q3 2025$17.2MBeat by $708.3KQ2 2025$17.2MBeat by $300.8KQ1 2025$15.5MBeat by $944.0KQ4 2024$13.7MMiss by $912.5K

Diluted EPS

Q1 2026-$0.17Beat by $0.07
Q4 2025-$0.20In line
Q3 2025-$0.19Miss by $0.06Q2 2025-$0.18In lineQ1 2025-$0.20In lineQ4 2024-$0.20Beat by $0.07

Ask the moment Exagen Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Exagen Inc. report Q4 2025 earnings?
Exagen Inc. (XGN) reported Q4 2025 earnings on March 10, 2026 before market open.
What were Exagen Inc.'s Q4 2025 revenue and EPS?
Exagen Inc. reported revenue of $16.6M and eps of $-0.20 for Q4 2025.
Did Exagen Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $16.6M by $60.7K. EPS beat the consensus estimate of $-0.20 by $0.00.
How did Exagen Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.8% from $13.7M a year earlier and eps grew 0.0% from $-0.20.
Where can I find Exagen Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001274737-26-000007) and the 10-K periodic report (0001274737-26-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.